Holdings in Company

Clean Power Hydrogen
28 April 2023
 

A picture containing food, game Description automatically generated

28 April 2023

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group)

Holdings in Company

Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free ElectrolyserTM, was notified on 26 April 2023 that Aurelius Limited now holds 20,448,881 ordinary shares in the Company, representing approximately 7.62% of the issued share capital of the Company. The Aurelius Limited shareholder was previously disclosed as the Manny Davidson Discretionary Trust.

For more information, please contact:

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer




Cenkos Securities plc - NOMAD & Broker


Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778



Camarco PR

+ 44(0) 203 757 4980

Billy Clegg


Owen Roberts


Lily Pettifar


 

Notes to Editors

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("CleanPower") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings